STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study

Our data suggest a novel therapeutic mechanism of STAR driven by increasing the effective refractory period in locally treated areas, corresponding to increased tissue wavelength. Our results corroborate clinical case reports and anecdotal evidence that STAR increases VT cycle length. Importantly, these effects were not mediated by an increase in myocardial scar burden. However, our studies do not examine the long-term effects of STAR.

Authors

Institutions

Publication Details

Journal
Circulation Arrhythmia and Electrophysiology
Published
2025-05-20
DOI
https://doi.org/10.1161/circep.124.013684
Citations
3
Primary Topic
Cardiac Arrhythmias and Treatments
Type
article
Field-Weighted Citation Impact
4.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study

Ali Javaheri, Samuel D. Jordan, Carmen Bergom, Aryan Kumar et al.
3 citations
Circulation Arrhythmia and Electrophysiology
Cardiac Arrhythmias and Treatments
4.16
article

STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study

Ali Javaheri, Samuel D. Jordan, Carmen Bergom, Aryan Kumar, El‐Sayed H. Ibrahim, Pamela Samson, Vinay P. Jani, Stacey Rentschler, Brian Zenger, Todd Pavek, Christian W. Zemlin, Luke Marut, Patrick M. Boyle, Sneha Manikandan, Jie Zheng, Sherwin Ng, Clifford G. Robinson, Phillip S. Cuculich, Geoffrey D. Hugo, Julie K. Schwarz, Stephanie N. Hicks, Timothy W. Smith, Leslie Dawn Wilson, Nels Knutson, Caleb Berberet, James Tabor
article en
3 citations

Abstract

Our data suggest a novel therapeutic mechanism of STAR driven by increasing the effective refractory period in locally treated areas, corresponding to increased tissue wavelength. Our results corroborate clinical case reports and anecdotal evidence that STAR increases VT cycle length. Importantly, these effects were not mediated by an increase in myocardial scar burden. However, our studies do not examine the long-term effects of STAR.

Circulation Arrhythmia and ElectrophysiologyVol. 18(6)
California Institute for Regenerative Medicine (US), Medical College of Wisconsin (US), Washington University in St. Louis (US), John Cochran VA Medical Center (US), Norwegian Womens Public Health Association (NO), Bioengineering Center (RU)
Good health and well-being
Openalex Percentile: Top 6%
Cardiac Arrhythmias and Treatments
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.